March 30, 2011 (Toronto, Ontario) — Caregivers using a transdermal patch to administer cholinesterase inhibitor (ChEI)–based therapy in individuals with Alzheimer's disease (AD) report greater overall ...
In a study aimed at finding answers for those with advanced Alzheimer’s disease, researchers at Saint Louis University are testing a new, higher dose of the Exelon (rivastigmine) patch to learn ...
A recent study from the University of Eastern Finland shows that among users of antidementia drugs, persons using memantine have the highest risk of pneumonia. The use of rivastigmine patches is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback